newsfilter
← Latest News
ClinicalTrials.gov·

A Study of Single Ascending Doses of VIB1116 in Rheumatic Diseases - NCT04948099

Incidence of treatment-emergent adverse events, serious adverse events, and adverse events of special interest, Serum concentration of VIB1116 and noncompartmental PK parameters, Change from baseline in the blood levels of plasmacytoid dendritic cells, (and 2 more...)